Edition:
India

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

3,185JPY
11:30am IST
Change (% chg)

¥135 (+4.43%)
Prev Close
¥3,050
Open
¥3,080
Day's High
¥3,240
Day's Low
¥3,080
Volume
273,700
Avg. Vol
137,708
52-wk High
¥3,240
52-wk Low
¥2,133

4552.T

Chart for 4552.T

About

JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Pharmaceutical business engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment... (more)

Overall

Beta: 1.20
Market Cap(Mil.): ¥95,643.65
Shares Outstanding(Mil.): 32.42
Dividend: 11.00
Yield (%): 0.75

Financials

  4552.T Industry Sector
P/E (TTM): 45.05 30.66 31.86
EPS (TTM): 65.48 -- --
ROI: 6.70 14.54 14.08
ROE: 7.68 15.62 15.39

BRIEF- JCR Pharmaceuticals to develop allogeneic regenerative medical product using DPCs with Teijin

* Says it entered into co-development and license agreement with Teijin Ltd, regarding JTR-161, an allogeneic regenerative medical product using dental pulp stem cells (DPCs) for the indication of acute cerebral infarction (stroke) for Japan, on July 18

18 Jul 2017

BRIEF-JCR Pharmaceuticals to dissolve Hebei-based subsidiary

* Says it plans to dissolve Hebei province-based subsidiary, which is engaged in pharmaceutical business

26 Apr 2017

BRIEF-JCR Pharmaceuticals initiates phase 1/2 clinical trial of jr-141 in hunter syndrome

* Says co initiates phase 1/2 clinical trial of jr-141 in hunter syndrome

31 Mar 2017

Earnings vs. Estimates